These data demonstrate that ABA, in particular an enriched fig extract, is a potent insulin-sensitizing compound that that modulates systemic inflammation and skeletal muscle metabolism and thereby it shows promise as a clinical candidate for treating pre-diabetes, type 2 diabetes and metabolic syndrome worldwide. Here, INS is linked to type 2 diabetes mellitus.